🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Damian Rieke

German Cancer Research Center

ORCID: 0000-0003-0027-7977

Also affiliated with Max Delbrück Center, Humboldt-Universität zu Berlin, German Cancer Society, German Centre for Cardiovascular Research, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Charité - Universitätsmedizin Berlin

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile
5.9Author DataRank

Indexed papers

3in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer

Nature Genetics(2020)10.1038/s41588-020-0603-8
Top 4%
4.9DataRank
Top 4%178 citations

Brian Walsh, Georgia Mayfield, David Tamborero, Dmitriy Sonkin, Kilannin Krysiak +34 more

Papers

Driven by 6 papers — median percentile 81. Top paper: “A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer”.

A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer

Nature Genetics(2020)10.1038/s41588-020-0603-8
Top 4%
4.9DataRank
Top 4%178 citations

Brian Walsh, Georgia Mayfield, David Tamborero, Dmitriy Sonkin, Kilannin Krysiak +34 more

CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebase

Nucleic Acids Research(2022)10.1093/nar/gkac979
Top 19%
1.0DataRank
Top 19%46 citations

Arpad Danos, Jason Saliba, Joshua F. McMichael, Adam Coffman, Susanna Kiwala +60 more

Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)

Genetics in Medicine(2022)10.1016/j.gim.2022.01.001
N/A
0.829DataRank · unranked
250 citations

Malachi Griffith, Arpad Danos, Beth A. Pitel, Subha Madhavan, Xue‐Lu Liu +42 more

Evolution of the open-access CIViC knowledgebase is driven by the needs of the cancer variant interpretation community

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.06.13.448171
Top 100%
0DataRank
Top 100%0 citations

Arpad Danos, Susanna Kiwala, Joshua F. McMichael, Adam Coffman, Erica K. Barnell +47 more

The basis for future personalized therapy approaches – Machine learning-generated 1-year survival rate, metastatic status and therapy-dependent survival in pancreatic cancer patients

European Journal of Cancer(2025)10.1016/j.ejca.2025.116189
N/A
0DataRank · unranked
3 citations

Haotian Chen, Uwe Pelzer, Richard G. Compton, Gregor Duwe, Mihnea P. Dragomir +13 more

Response to: The pathway alteration load is a pan-cancer determinant of outcome of targeted therapies: results from the Drug Rediscovery Protocol (DRUP)

ESMO Open(2025)10.1016/j.esmoop.2025.104516
N/A
0DataRank · unranked
0 citations

Razelle Kurzrock, Damian Rieke